Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Net Cash Flow (2020 - 2025)

Sight Sciences has reported Net Cash Flow over the past 6 years, most recently at -$406000.0 for Q4 2025.

  • Quarterly results put Net Cash Flow at -$406000.0 for Q4 2025, down 122.64% from a year ago — trailing twelve months through Dec 2025 was -$28.1 million (down 58.27% YoY), and the annual figure for FY2025 was -$28.1 million, down 58.27%.
  • Net Cash Flow for Q4 2025 was -$406000.0 at Sight Sciences, up from -$8.9 million in the prior quarter.
  • Over the last five years, Net Cash Flow for SGHT hit a ceiling of $235.9 million in Q3 2021 and a floor of -$22.1 million in Q1 2022.
  • Median Net Cash Flow over the past 5 years was -$10.8 million (2021), compared with a mean of $1.5 million.
  • Biggest five-year swings in Net Cash Flow: soared 2749.4% in 2021 and later plummeted 2390.44% in 2025.
  • Sight Sciences' Net Cash Flow stood at -$10.8 million in 2021, then plummeted by 37.37% to -$14.8 million in 2022, then soared by 57.0% to -$6.4 million in 2023, then skyrocketed by 128.14% to $1.8 million in 2024, then plummeted by 122.64% to -$406000.0 in 2025.
  • The last three reported values for Net Cash Flow were -$406000.0 (Q4 2025), -$8.9 million (Q3 2025), and -$7.3 million (Q2 2025) per Business Quant data.